Arkolith/Insider Trading/IMVT/Form 4

Venker Eric

Chief Executive Officer, DirectorImmunovant, Inc. (IMVT) · full profile →Form 4 · filed Jul 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$119K
Net Open-Market Flow
-$119K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 2, 2026Sell(S)3K$38.48$119K254K
Jul 1, 2026Option exercise(M)92K$14.46$1.3M344K
Jul 1, 2026Disposed to issuer(D)87K$38.14$3.3M257K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2026Option exercise(M)92K—$01.0M

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001764013-26-000077) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML